Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)

CAPS Rating: 2 out of 5

A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.

Recs

0
Player Avatar SnarkyApple (50.74) Submitted: 9/18/2012 12:34:12 PM : Underperform Start Price: $1.83 CPRX Score: +75.87

Shenanigans.

Featured Broker Partners


Advertisement